Author

Sreenivas Nannapaneni

GlaxoSmithKline (United States)ORCID 0000-0002-3869-6512Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:rat· 1

Frequent Co-Authors

Bradley Spencer‐DeneiD· 1 shared Dinesh Stanislaus· 1 shared Joel D. Parry· 1 shared Joyce Rendemonti· 1 shared Sara M Bender· 1 shared Sharon Chapman· 1 shared Stanley Robinson· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Bradley Spencer‐DeneORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Rat and rabbit whole embryo culture as a new approach method for unlabeled therapeutic antisense oligonucleotide hazard identification with no requirement for microinjection or assisted transfection

Sara M Bender, Sharon Chapman, Sreenivas Nannapaneni, Joel D. Parry, Joyce Rendemonti, Stanley Robinson, Bradley Spencer‐Dene, Dinesh Stanislaus

This paper shows that rat and rabbit whole embryo culture can identify developmental hazards of antisense oligonucleotides without microinjection or transfection, using mipomersen as a test case.

Nucleic Acid Therapeutics · May 4, 2026Peer-reviewedPharmacology & Toxicology